Researchers propose new strategy to improve efficiency for nanotherapeutic delivery in tumors [23-10-2023]
A team led by Prof. Wang Yucai and Associate Prof. Jiang Wei from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences (CAS) revealed the mechanism of the tumor vascular basement membranes (BM) blocking nanoparticles (NPs) for the first time and developed an immunodriven strategy to increase the NP penetration through the BM barrier.
Related News
A nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment [01-02-2024]
Metal-free graphene quantum dots show promise for highly efficient tumor therapy [12-01-2024]
Nanomedicine, Graphene, Quantum Science
Using AI, researchers identify a new class of antibiotic candidates that can kill a drug-resistant bacterium [20-12-2023]
Nanobiotechnology, Nanomedicine, Artificial intelligence
Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000 [22-09-2023]
Nanobiotechnology, Nanomedicine
NBRAIN Neuroelectronics Announces FDA Breakthrough Device Designation for Its Graphene-Based Intelligent Network Modulation Platform [19-09-2023]
Nanomedicine, Graphene

© Phantoms Foundation 2024